
Revenues at Roche flattened out in the first three months of 2011, as Avastin sales declined in the US and Europe. Group …
Watermeadow Medical is delighted to welcome seven new staff to its UK offices. The appointments have been made as demand …

GPs are being asked not to prescribe NICE-approved drugs in order to cut costs.In the last year more than half …

Swiss contract manufacturer and fine chemicals company Lonza has said it plans to expand its biopharmaceutical production unit in Slough, …
The FDA advisory committee has unanimously backed Novartis’ Afinitor for neuroendocrine tumours of pancreatic origin. The recommendation comes from the …

Astellas has appointed Ken Jones as its president and chief executive in Europe. Jones had been the chief operating officer …
Novartis has stopped a late stage study of Tasigna for certain types of stomach cancers after it failed to show …
Wainwright Associates are offering you the opportunity to attend a FREE thirty minute webinar on “The roles and responsibilities of …
A small New Zealand company is trying to find European contract manufacturing partners to help it scale up production of …

Indian firm Dr Reddy’s has confirmed the UK is still attractive for investment as it opens its new pharma services …

Merck Inc has created a joint venture with Indian firm Sun Pharmaceutical Industries to develop, manufacture and market branded generics …
Cherwell Laboratories of the UK has opened a new manufacturing and warehousing facility for its microbiological media and environmental monitoring …
GlaxoSmithKline has started pilot testing of a wireless system of flow and pressure transmitters to try to improve the efficiency …
Bayer and partner Regeneron have begun late stage trials for their VEGF Trap Eye candidate for diabetic macular oedema. The …
The European Commission has granted marketing authorisation for Trobalt, the new epilepsy drug from GSK and Valeant. Trobalt (retigabine) has …
Japanese pharma company Eisai has set up its first operations in Latin America, establishing a sales subsidiary in Brazil. Based …
Chime’s newly-launched healthcare comms shop Open Health has bought established UK health advertising agency Lane, Earl & Cox. It will …
AstraZeneca’s Zactima has become the first treatment to be approved for a rare form of thyroid cancer. The orphan drug …

The government has paused its reforms of the NHS and launched what it calls a ‘listening exercise’ to regain support …

Healthcare research agency HRW has promoted Gillian Newbold to its board of directors. Gillian joined the Oxfordshire, UK-based company in …